Popular Keywords

Anaplastic lymphoma kinase

Biological therapies

Biomarkers

Cancer

Chemoradiotherapy

Clinical trials

Editorial-Board

  • Guryanova Svetlana Vladimirovna
    Biology Department of Moscow State University,Russia
  • Junpeng Chen
    Hunan University of Science and Technology, Australia
  • Mirjana Rajer
    Medical Oncologist, University Medical Center Ljubljana, Slovenia (Department of Hematology),Italy
  • Ghaith
    Royal Infirmary of Edinburgh,United Kingdom
  • Tasnim Tonni
    Daffodil International University,Bangladesh
  • Suvilesh Kanve Nagaraj
    University of Missouri,United States of America

Journal Info

  • Journal Name: The Clinical Lung Cancer
  • Impact Factor: 1.8
  • ISSN: 3064-6693
  • DOI: 10.52338/tclc
  • Short Name: Tclc
  • Acceptance rate: 55%
  • Volume: 7 (2024)
  • Submission to acceptance: 25 days
  • Acceptance to publication: 10 days
  • Crossref indexed journal
  • Publons indexed journal
  • Pubmed-indexed journal
  • International Scientific Indexing (ISI)-indexed journal
  • Eurasian Scientific Journal Index (ESJI) index journal
  • Semantic Scholar indexed journal
  • Cosmos indexed journal

OUR PUBLICATION BENEFITS

  • International Reach
  • Peer Review
  • Rapid Publication
  • Open Access
  • High Visibility